Готові списки джерел за темами / Palliative treatment

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій
Звіти організацій

Добірка наукової літератури з теми "Palliative treatment"

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 29 липня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Palliative treatment".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Palliative treatment"

Baka, Sofia, Paul Lorigan, and Nick Thatcher. "Palliative treatment." Hematology/Oncology Clinics of North America 18, no. 2 (April 2004): 417–32. http://dx.doi.org/10.1016/j.hoc.2003.12.001.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bjordal, K. "Palliative medical treatment." Radiotherapy and Oncology 82 (February 2007): S16. http://dx.doi.org/10.1016/s0167-8140(07)80054-5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kon, Alexander A., and Arthur R. Ablin. "It's not palliative care, it's palliative treatment." Lancet Oncology 10, no. 2 (February 2009): 106–7. http://dx.doi.org/10.1016/s1470-2045(09)70011-7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Patell, Rushad, David Johnson Einstein, Jennifer Halleck, and Mary K. Buss. "Patient perceptions of treatment benefit in advanced cancer." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e23163-e23163. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e23163.

Повний текст джерела

Анотація:

e23163 Background: Informed consent assumes accurate perceptions of potential benefits and risks of treatment, yet many patients receiving palliative cancer therapies misperceive the likelihood of cure. Our study aims to further explore patient perceptions of benefits and risks of palliative treatments and to examine this in the era of novel therapeutics. Methods: We surveyed patients with advanced solid cancers and their oncologists regarding benefits/risks of palliative therapies. We serially assessed patients’ perceptions of likelihood of tumor response, survival benefit, symptom palliation and side effects, as well as information-seeking behavior pre-treatment and decisional regret at the end of treatment. We also compared patients’ perceptions of benefits/risks to that of their oncologists. Results: Across four disease groups, 52 patients have enrolled (target accrual: 120). Median age is 64 years (range 20-84), 58% are male, and 60% had prior treatment. Treatments included chemotherapy (42%), targeted therapy (31%), and immunotherapy (27%). Misperceptions (patient-assessed likelihood minus oncologist-assessed likelihood) at the beginning of treatment across different domains are shown in the table. Conclusions: Compared with their oncologists, patients overestimate not only curability but also chance of tumor response, symptom palliation, and survival benefit, yet they accurately perceive chance of toxicity. Thus, efforts at improving communication should focus on the chances of treatment benefit and multiple types of benefits rather than treatment risks. In future analyses after full accrual, we will assess differences between domains, internal consistency of misperceptions, change in misperceptions over time on treatment, decisional regret at end of treatment, and association of misperceptions with information-seeking behavior and sources of education. [Table: see text]

Стилі APA, Harvard, Vancouver, ISO та ін.

Mishreki, AP, E. Lim, P. Cranefield, S. Pascoe, S. Jackson, and DA Stell. "Low rate of active treatment of patients with hilar cholangiocarcinoma." Annals of The Royal College of Surgeons of England 95, no. 5 (July 2013): 349–52. http://dx.doi.org/10.1308/003588413x13629960046598.

Повний текст джерела

Анотація:

Introduction The results of surgical resection and palliative chemotherapy use in hilar cholangiocarcinoma (HC) have been well publicised but the proportion of patients able to undergo these treatments and the comparative outcomes in a population of patients with HC are less well known. Methods Patients with HC were identified by review of all patients undergoing percutaneous cholangiography over a nine-year period (2002–2010) in a tertiary facility. The treatment undertaken and outcomes were recorded. Results Overall, 68 patients were identified (37 female) with a median age of 70 years. Forty-five (66%) were treated solely by insertion of a metal stent (median survival 4.73 months) and nine (13%) also received palliative chemotherapy (median survival 13.7 months). Persisting jaundice after stent insertion was noted in 18 of 35 patients (51%) tested within one month of death. Fourteen patients (21%) underwent surgical resection (median survival 20.2 months). Conclusions Patients undergoing surgical resection had significantly longer survival than those receiving only a palliative stent but not compared with those also receiving palliative chemotherapy, with short-term follow-up. Only a third of patients, however, receive active treatment (surgery or chemotherapy) and improvements in long-term biliary palliation are needed.

Стилі APA, Harvard, Vancouver, ISO та ін.

Patell, Rushad, David Johnson Einstein, Jennifer Halleck, Laura Dodge, and Mary K. Buss. "Patient perceptions of treatment benefit in advanced cancer." Journal of Clinical Oncology 37, no. 31_suppl (November 1, 2019): 25. http://dx.doi.org/10.1200/jco.2019.37.31_suppl.25.

Повний текст джерела

Анотація:

25 Background: Informed consent assumes accurate perceptions of potential treatment benefits and risks, yet many patients receiving palliative cancer therapies misperceive the likelihood of cure. Patients’ understanding of treatment benefits/risks beyond cure is unknown. We aimed to further explore patient perceptions of benefits/risks of palliative treatment in the era of novel therapeutics. Methods: We surveyed patients with advanced solid cancers and their oncologists regarding benefits/risks of palliative therapies. We assessed perceived likelihood of tumor response, survival benefit, symptom palliation and side effects, as well as information-seeking behavior. We used log binomial regression to estimate risk ratios (RR) and 95% confidence intervals (CI) of the association between misperception (patient perception minus physician’s perception) and various demographic, disease and treatment characteristics. Results: Of 119 patients enrolled: median age was 65 years (range 59–73), 55% male and 56% had prior treatment. Treatments included chemotherapy (60%), immunotherapy (25%) and targeted therapy (16%). Median misperceptions are shown in Table. Factors associated with decreased misperception included male gender (RR=0.70, 95% CI: 0.55–0.89), graduate level education (RR=0.63, 95% CI: 0.41–0.98) and targeted therapy (RR=0.54, 95% CI: 0.30–0.98). There was no correlation between misperceptions of tumor response and curability (r=0.13, P=0.15) or self-education (r=-0.04, P=0.69). Conclusions: Compared with their oncologists, patients’ overestimate not only curability but also chances of tumor response, symptom palliation and survival benefit; though they accurately perceive likelihood of toxicity. There is no correlation between perception of curability and other goals of therapy such as response rate and symptom palliation. Improvements in communication should focus on the likelihood of different treatment goals rather than treatment risks. [Table: see text]

Стилі APA, Harvard, Vancouver, ISO та ін.

Porzsolt, F., and I. Tannock. "Goals of palliative cancer therapy." Journal of Clinical Oncology 11, no. 2 (February 1993): 378–81. http://dx.doi.org/10.1200/jco.1993.11.2.378.

Повний текст джерела

Анотація:

The major conclusions of the Workshop on Goals of Palliative Cancer Therapy are as follows: 1. The goals of any cancer therapy should be stated explicitly. 2. If the goal of treatment is palliation, this should be documented according to one of the established and validated methods for assessment of quality of life. Several validated methods are available, and although imperfect, have been shown to give reliable information. 3. The use of simple measures of quality of life (eg, symptom checklists, pain assessment cards) should become routine in oncology practice. The act of introducing such measures improves palliation. 4. Measures of cost-effectiveness should be used more widely in clinical decision making to ensure the appropriate deployment of resources. 5. There must be improved education of all health professionals with regard to the multiple methods for provision of palliative treatment to cancer patients and the assessment of palliation.

Стилі APA, Harvard, Vancouver, ISO та ін.

Revannasiddaiah, Swaroop, RajeevK Seam, Manish Gupta, Madhup Rastogi, ManojK Gupta, and Priyanka Thakur. "When palliative treatment achieves more than palliation: Instances of long-term survival after palliative radiotherapy." Indian Journal of Palliative Care 18, no. 2 (2012): 117. http://dx.doi.org/10.4103/0973-1075.100829.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Jeba, Jenifer, Ansu Mary Thankachan, Annie Jacob, Ramu Kandasamy, and D. N. Susithra. "COVID-19 – Initial Lockdown: Implications on Cancer Treatment among Palliative Care Outpatients." Indian Journal of Palliative Care 28 (March 16, 2022): 3–6. http://dx.doi.org/10.25259/ijpc_314_20.

Повний текст джерела

Анотація:

Objectives: The pandemic and the lockdown has challenged palliative care patients especially those on palliative oncological treatments. This study aims to understand the effect of COVID-19 and initial lockdown on palliative oncological treatments among palliative care patients. Materials and Methods: A retrospective chart review of patients who attended the palliative care outpatient clinic, between 21 April and 12 May 2020, was done. Sociodemographic and palliative oncological treatment details were reviewed. Results: Of the 107 patients included, 53.7% were between 40 and 60 years of age, and 58.3% were women. A large proportion (63%) was unemployed and 40.2% had to rent vehicles for hospital travel. During this period, palliative oncological treatment was interrupted or deferred in 20% and 3.5%, respectively. During this period, homecare services were also affected in about 12.2% of our patients. Conclusion: The COVID-19 pandemic and the lockdown have affected the palliative oncological treatment of palliative care outpatients with cancer. The implications of interrupted and deferred treatment on patient outcomes would be seen in the months and years to follow. Palliative care teams should enhance patient and caregiver support and promote non-abandonment and continuum of care during such unprecedented times.

Стилі APA, Harvard, Vancouver, ISO та ін.

Volpe, Bruce T. "Palliative treatment for stroke." Neurologic Clinics 19, no. 4 (November 2001): 903–20. http://dx.doi.org/10.1016/s0733-8619(05)70053-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Palliative treatment"

Greaves, Judith M. "Understanding palliative care: An ethnographic study of three Australian palliative care services." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2005. https://ro.ecu.edu.au/theses/1553.

Повний текст джерела

Анотація:

Palliative care commenced in Australia in the early 1980s. Although the value of palliative care has become more widely recognised by the public and other health care professionals, there is still a lack of understanding about what palliative care is and the depth and scope of this specialty area of health care. The research that I present in this thesis is based on examination of palliative care practice in a selection of Australian services, undertaken with the aim of enhancing understanding of Palliative Care. The significance of the research arises from the notion that members of the Australian community should be well informed about health care options available to them. Understanding palliative care and the ability to differentiate palliative care from other end-of-life care is important if people are to make informed decisions about supporting, accessing, and using services appropriate to their needs. An interpretive ethnographic study from a symbolic interactionist perspective was undertaken in three palliative care services, one in each of the major Australian cities of Sydney. Melbourne, and Perth. Each palliative care service had been established for at least ten years, and was part of a larger health care facility. A fourth service, a purpose-built three-year-old unit, was added during the course of the research to provide contrast to the emerging analyses. As an experienced palliative care nurse, I assumed the role of marginal native as the primary research instrument. Data collection was by means of participant observation, formal and informal interviews, and examination of supplementary data sources, with two months spent in each of the three study sites. Interpretations made from ethnographic observation of these Australian palliative care services showed a diversity of practice, best understood within the context of the particular service. The major findings are presented under the headings of Politics, Place, People, and Practice of Palliative Care. Common approaches to provision of care were found in creating an appropriate physical environment for patients, with an underlying mission to "make the best of things." Patients cared for in the settings were a similar cohort of middle aged to elderly cancer patients. In general, staff shared expectations of appropriate types of patients and showed discomfort or lack of understanding in caring for non-cancer patients, or patients from non-Australian, non-Christian, and non-English speaking backgrounds. Practice diversity was highlighted by the range of technology used and variations in the availability of social activities for patients in the services. These two: areas in particular warrant further research to examine the outcomes associated with these variations, in terms of survival time, quality of life, and service costs. These findings are particularly relevant at this time when the Australian Government is attempting to enhance access to palliative care. The diversity of practice uncovered in this study suggests that discussions and decisions about allocation of resources and development of services must take into consideration the various interpretations of palliative care services that may exist. The findings also reinforce the need for sound evidence-based studies to examine the impact of variations and the types of populations that might be best served by different types of palliative care support.

Стилі APA, Harvard, Vancouver, ISO та ін.

Chandrasekhara, Seetha. "Palliative Treatment and Euthanasia for Psychiatric Illnesses." Master's thesis, Temple University Libraries, 2017. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/425660.

Повний текст джерела

Анотація:

Urban Bioethics
M.A.
When looking at the natural course of life, death is the natural conclusion. Majority of the time, people do not choose when and how they die. Death and dying are topics that are difficult to discuss for many individuals. However, when one decides to choose the context of their death, it raises many ethical considerations. Psychiatry, as a field, looks at the psychodynamics of death and dying for individuals. It is also poised to comment on the growing use of physician-assisted suicide and euthanasia for psychiatric disorders. Through a review of the literature, theories in psychiatry regarding the dying process are used to better understand an individual's choice for choosing euthanasia as a medical intervention to end their suffering from a long-standing psychiatric illness. The use of palliative care in conjunction with psychiatry is also explored.
Temple University--Theses

Стилі APA, Harvard, Vancouver, ISO та ін.

Bradley, Sarah Elizabeth. "Specialist palliative day care : patients' perspectives." Thesis, University of Hull, 2009. http://hydra.hull.ac.uk/resources/hull:3970.

Повний текст джерела

Анотація:

This portfolio has three parts. Part one is a systematic literature review entitled ‘Patients' Psychosocial Experiences of Attending Specialist Palliative Day Care: A Systematic Literature Review’. Recent reviews conclude that the benefits of attending Specialist Palliative Day Care are likely to be in the social, psychological and spiritual domains. However these areas are not easily identified, leaving researchers and practitioners unclear as to what aspects of these domains patients most need and desire. The objective of this review was to systematically evaluate literature on patient perceived psychosocial experiences of attendance at SPDC. Twelve studies were included. Evidence showed that patients value a person-centred approach which reduces isolation, increases social support, encourages communication and provides activities. Future research could focus on investigating why patients value the psychosocial experiences reported in this review and how these experiences can be defined in a way that would be meaningful to clinical service commissioners. Once this has been done, clinicians can start to measure clinical effectiveness and devise justifiable interventions for this patient group. Part two is a qualitative study, using Interpretative Phenomenological Analysis (IPA) to explore patients’ perspective of attending SPDC. The importance of services helping patients cope with terminal illness has been emphasised throughout Department of Health (2000) and NICE (2004) cancer guidance. However, whether or not services are achieving this aim has been sparsely researched to date; particularly in relation to Specialist Palliative Day Care (SPDC). Eleven semi-structured interviews were carried out and analysed utilising qualitative methodology (Interpretative Phenomenological Analysis – IPA) to allow for an in depth investigation of SPDC. Emerging themes suggest that SPDC provides an environment in which patients are helped to cope by facilitation of acceptance of the reality of death, thereby freeing them to focus on 'life'. The study does not claim to provide the definitive answer to what processes may underpin attendance at SPDC, however in such an under researched area it provides a much needed exploration which can be built upon or challenged by future research. Part three comprises appendices relating to the research. This includes a reflective statement on the process of conducting the research, the challenges faced and the lessons learnt.

Стилі APA, Harvard, Vancouver, ISO та ін.

Fourie, Linda. "Pain control in palliative care : a South African nursing perspective." Thesis, [S.l. : s.n.], 2008. http://dk.cput.ac.za/cgi/viewcontent.cgi?article=1029&context=td_cput.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ramadge, Joanne, University of Western Sydney, College of Social and Health Sciences, and of Nursing Family and Community Health School. "Ways of knowing cancer pain in a palliative care setting." THESIS_CSHS_NFC_Ramadage_J.xml, 2001. http://handle.uws.edu.au:8081/1959.7/428.

Повний текст джерела

Анотація:

Very little work has been undertaken that explores pain as a part of human existence and the inherent knowledge that accompanies it. What pain means to people and how they know their own pain is the subject of this research study.The research sought to identify ways of knowing cancer pain of six participants, each receiving palliative care at the time of this study. The themes of, balancing conflict, living with threat, always there and making sense are identified and examined to provide understanding of the ways these people know their pain. A new model of pain assessment is offered that incorporates an ontological way of knowing, and the meaning that the findings have for nursing practice is explored. Implications for nursing practice and education that are derived from the study are offered. The rigour of the study is promoted through an audit process
Doctor of Philosophy (PhD)

Стилі APA, Harvard, Vancouver, ISO та ін.

Mitchell, Geoffrey Keith. "The effect of case conferences between general practitioners and palliative care specialist teams on the quality of life of dying people /." [St. Lucia, Qld.], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18557.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bergquist, Adam. "Evaluation of the pathways palliative care program at the Denver hospice." [Denver, Colo.] : Regis University, 2008. http://165.236.235.140/lib/ABergquist2008.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Uwimana, Jeannine. "Met and unmet palliative care needs for people living with HIV/AIDS in selected areas in Rwanda." Thesis, University of the Western Cape, 2005. http://etd.uwc.ac.za/index.php?module=etd&amp.

Повний текст джерела

Анотація:

The aim of this study was to investigate met and unmet palliative care needs for people living with HIV/AIDS in selected areas in Rwanda. The achieve this aim, the study, firstly, identified the palliative care needs of people living with HIV/AIDS, secondly, it identified the health care services available to meet these needs, and thirdly, it determined the extent to which palliative care needs were met.

Стилі APA, Harvard, Vancouver, ISO та ін.

Liu, Chang-Han. "Effectiveness of palliative measures in treatment of dysphagia of cancer of the oesophagus." Master's thesis, University of Cape Town, 2005. http://hdl.handle.net/11427/11191.

Повний текст джерела

Анотація:

Includes bibliographical references (leaves 34-35).
Cancer of the oesophagus,one of the most common cancers amongst the black population in South Africa with "cure" in this condition often considered as a "fortunate accident" by many experts in the field of oncology due to its late presentation and common occurrence of metastasis at presentation. The palliative care team focused their attention on measures to solve the cardinal symptom of this disease, which in most cases was dysphagia. This was also the main determinant of quality of life for these patients. Therefore, the primary objective of the study was to determine the effectiveness of the palliative measures in improving the cardinal symptom of oesophageal carcinoma - dysphagia. Accurate staging in most, if not all of the cancers is paramount, as it determines which options and sequences of treatment are appropriate. Oesophageal carcinoma is no exception. For patients stage III/IV, surgical resection of the tumour was attempted if possible. For advanced stage oesophageal carcinoma, that is stage III/IV, surgical resection with curative intent was not performed. The cardinal symptom of oesophageal carcinoma was then treated mainly with palliative radiotherapy, dilatation of the oesophagus with flexible bougie and oesophageal intubations.

Стилі APA, Harvard, Vancouver, ISO та ін.

Painter, Mark Llewellyn. "Outcome after palliative cardiac surgery in a developing country." Master's thesis, University of Cape Town, 1990. http://hdl.handle.net/11427/25963.

Повний текст джерела

Анотація:

The outcome of 121 children who underwent palliative cardiac surgery at the Red Cross War Memorial Children's Hospital over a 5 year period, 1980 1984, was retrospectively examined. 79 children had systemic artery to pulmonary artery shunt operations (SPS), 40 had pulmonary artery bands (PAB) and 2 had surgical septectomies. SPS was most often done for children with Tetralogy of Fallot (TOF, 26 cases) or complex univentricular hearts with right ventricular outflow tract obstruction (27 cases). PAB was done chiefly for ventricular septa! defects, alone (VSD, 8 cases) or with coarctation of the aorta (9 cases). Children were referred from a wide area with 63 cases being referred from other major centres and foreign countries. Overall, 36 children died (30 % mortality): 5 died at surgery, 6 within 48 hours of surgery, a further 5 within 31 days; and 20 died after 31 days. SPS and PAB had the same early mortality rates ( 13 % ) • SPS had higher late and overall mortality rates (20 and 33 %) than PAB (10 and 23 %). Age at operation was found to be the most significant determinant of the overall mortality rate: children less than six months had a mortality of 42 % and those over 6 months, 13 % • The children were grouped into those with lesions which were probably correctable and those that were unlikely to be so, based on diagnosis and age at surgery: those with correctable lesions had a lower overall mortality (22 %) than those with uncorrectable lesions (43 %). Where the surgery was performed as an emergency, there was a higher overall and early mortality (55 and 35 respectively), compared to those operations which were performed electively ( 25 and 9 % ) • The presence of other medical conditions, for example congenital abnormalities and infections, was also a determinant of death (44 % mortality if other medical condition present, 26 % if absent). sex, population group, home address and type of surgery performed did not significantly affect mortality when examined by multivariate analysis. Using routine methods of follow up, it was initially thought that 17 % of all patients (22 % of survivors) were lost to follow up. An important determinant of this was the referral centre. 31 % of cases from other major centres and 20 % of foreign cases were lost, as compared to 8 % of cases from smaller towns near Cape Town and 2 % of children from Cape Town. Population group (35 % Blacks, 14 % Coloureds and 7 % Whites were lost), and palliative operation (23 % SPS, and 5 % PAB lost) were also significant determinants. It was possible to trace 12 of the 20 children who were thought to be lost to follow. 8 had died, 3 were still awaiting correction and 1 was traced and received corrective surgery. The records of the children who underwent cardiac surgery in 1987 were also analysed. There was no difference in the demographic characteristics of either group, and the early mortality was the same. This study shows that the outcome after palliative cardiac surgery is poor, with a high mortality rate and children often being lost to follow up. The decision to palliate rather than to correct a congenital heart defect must be made after balancing these risks with those of early correction for the particular surgical team. Should palliative surgery be undertaken, careful follow up is essential to ensure that complications of palliation do not set in and that corrective surgery is done at the optimal time.

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Книги з теми "Palliative treatment"

P, Dunn Geoffrey, and Johnson Alan, eds. Surgical palliative care. Oxford: Oxford University Press, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bass, Madeline. Palliative Care Resuscitation. New York: John Wiley & Sons, Ltd., 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Twycross, Robert G. Palliative care formulary. Oxford: Radcliffe Medical Press, 1998.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Derek, Doyle, ed. Oxford textbook of palliative medicine. 3rd ed. Oxford: Oxford University Press, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Buckley, Jenny. Palliative Care. New York: John Wiley & Sons, Ltd., 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

P, Dunn Geoffrey, ed. Surgical palliative care. Philadelphia: Saunders, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Mervyn, Dean, ed. Symptom relief in palliative care. Oxford: Radcliffe Publishing, 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Campbell, Heather. Palliative care. Harlow, England: Pearson Education, 2012.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kränzle, S. Palliative Care. 3rd ed. Heidelberg: Springer Medizin, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Jones, Charmaine. The palliative patient: Principles of treatment. Edited by Pegis Jessica and Knoll Pharma Inc. Markham, Ont: Knoll Pharma, 1994.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "Palliative treatment"

Kurth, K. H. "Palliative Treatment." In Clinical Practice in Urology, 263–97. London: Springer London, 1985. http://dx.doi.org/10.1007/978-1-4471-1362-1_11.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Scartozzi, Mario, Walter Siquini, Alessandro Bittoni, Luca Faloppi, and Stefano Cascinu. "Palliative Treatment." In Surgery in the Multimodal Management of Gastric Cancer, 209–14. Milano: Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2318-5_27.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Sibio, Simone, Joseph Maher Fouad Atta, Daniele Biacchi, Enzo Naticchioni, and Maurizio Cardi. "Palliative Treatments." In Treatment of Peritoneal Surface Malignancies, 349–60. Milano: Springer Milan, 2015. http://dx.doi.org/10.1007/978-88-470-5711-1_23.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lai, E. C. H., S. H. Y. Lau, and W. Y. Lau. "Palliative Surgical Treatment." In Hilar Cholangiocarcinoma, 291–96. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6473-6_27.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Guglielmi, Alfredo, Andrea Ruzzenente, and Calogero Iacono. "Palliative Treatments." In Surgical Treatment of Hilar and Intrahepatic Cholangiocarcinoma, 175–84. Milano: Springer Milan, 2007. http://dx.doi.org/10.1007/978-88-470-0729-1_16.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Slaney, Geoffrey, Jean Powell, Christopher C. Mcconkey, John A. H. Waterhouse, and Ciaran B. J. Woodman. "Palliative or No Treatment." In Cancer of the Large Bowel, 175–83. London: Macmillan Education UK, 1991. http://dx.doi.org/10.1007/978-1-349-11420-7_7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Pasquali, Paola. "Palliative Treatment with Cryosurgery." In Cryosurgery, 259–68. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43939-5_21.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Selinger, Christian P. "Palliative Treatment of Dysphagia." In Handbook of Nutrition and Diet in Palliative Care, 179–91. Second edition. | Boca Raton : Taylor & Francis, 2019. | Preceded by Diet and nutrition in palliative care / edited by Victor R. Preedy. c2011.: CRC Press, 2019. http://dx.doi.org/10.1201/9781315160627-16.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Shinde, Arvind M., and Azadeh Dashti. "Palliative Care in Lung Cancer." In Cancer Treatment and Research, 225–50. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40389-2_11.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bruera, Eduardo, and Jose Pereira. "The research palliative care unit." In Cancer Treatment and Research, 161–83. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-5003-7_9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Palliative treatment"

Ngo-Stuyt, L., M. Bulut, and I. Gögenur. "Palliative treatment of colorectal cancer using electroporation." In ESGE Days 2024. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1783724.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kumi, Paulette, Myrna Scott, and Deborah Dawson. "26 Present absentees: treatment escalation planning." In Marie Curie Palliative Care Research Conference. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/spcare-2019-mariecuriepalliativecare.26.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Mann, Charlotte. "12 Opioids in palliative care: initiating drug treatment." In Marie Curie Palliative Care Research Conference. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/spcare-2019-mariecuriepalliativecare.12.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Zavodnov, Victor Y., M. I. Kuzin, Sergey S. Kharnas, Kirill G. Linkov, Victor B. Loschenov, Alexander A. Stratonnikov, and Anna M. Posypanova. "Palliative treatment of patients with malignant structures of esophagus." In BiOS Europe '95, edited by Benjamin Ehrenberg, Giulio Jori, and Johan Moan. SPIE, 1996. http://dx.doi.org/10.1117/12.230999.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Santos, AL, F. Vilas-Boas, R. Morais, P. Pereira, and G. Macedo. "ENDOSCOPIC RADIOFREQUENCY ABLATION FOR PALLIATIVE TREATMENT OF HILAR CHOLANGIOCARCINOMA." In ESGE Days. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1704637.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Morais, R., F. Vilas-Boas, J. Antunes, P. Pereira, and G. Macedo. "ENDOSCOPIC RADIOFREQUENCY ABLATION FOR PALLIATIVE TREATMENT OF HILAR CHOLANGIOCARCINOMA." In ESGE Days 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1681427.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Stähr, Kerstin, Lisa Zimmer, Elisabeth Livingstone, Christoph Pöttgen, Stefan Mattheis, Stephan Lang, and Friederike Kaster. "T-VEC in the palliative treatment of Mucosal Melanoma." In 95th Annual Meeting German Society of Oto-Rhino-Laryngology, Head and Neck Surgery e. V., Bonn. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1785079.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Carneiro, Laura Beatriz Rocha Falcão, Ana Carolina Santos Huoya, Dálete Guímel Correia Santos, Isabela Gonçalvez de Araujo Sousa, João Paulo Velloso Medrado Santos, Maria Fernanda Passos Rocha Ramos, Raiane Aparecida Santos Nascimento, and Victoria Maria Novais. "PALLIATIVE CARE: A MULTIPROFESSIONAL APPROACH IN PATIENTS WITH BREAST CANCER." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2051.

Повний текст джерела

Анотація:

Objective: The aim of this study was to describe the importance of the multidisciplinary team in the management of pain in patients with breast cancer under palliative care. Methods: This is a qualitative literature review based on the analysis of studies available in the databases “SciELO”, “PubMed”, and Google Scholar platform. Aspects such as the particular needs of different patients, the views, and participation of the various health professionals involved in the treatment as well as the patients’ family network and affinities and their perceptions of the benefits of such an approach were considered. The descriptors used were the terms “Palliative Care”, “Breast Cancer”, and “Multidisciplinary Team”. Studies published between 2018 and 2022 and available in Portuguese or English were selected. Results: Among the materials analyzed, it is evident that palliative care for breast cancer should include a multiprofessional team, which aims to meet most of the individual’s needs. In addition, it can be observed that the insertion of this approach into the treatment of the patient improves adherence and awareness about the disease, thus interfering in the improvement of physical and psychosocial symptoms, resulting in an improvement in the quality of life of the patient. However, the lack of knowledge of patients and families about palliative care causes late and unplanned referrals. Conclusion: It is found that breast cancer is a multifaceted disease that covers several dimensions that make up the biopsychosocial being. Consequently, care must be prepared by a multidisciplinary team in order to improve adherence to treatment and education about the disease and, finally, care for the patient in its entirety, reducing their suffering.

Стилі APA, Harvard, Vancouver, ISO та ін.

LeBlanc, Thomas W. "P1-2 Integrating palliative care aside curative treatment in hemato-oncological disease." In Sapporo Conference for Palliative and Supportive Care Abstracts. British Medical Journal Publishing Group, 2023. http://dx.doi.org/10.1136/spcare-2023-scpsc.15.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Dorman, Saskie, Rebekah Wetherly Wilson, Gemma Hasnaoui, Clive Hunt, and Simon Jackson. "82 Treatment escalation plans – supporting individualised care." In The APM’s Annual Supportive and Palliative Care Conference, In association with the Palliative Care Congress, “Towards evidence based compassionate care”, Bournemouth International Centre, 15–16 March 2018. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/bmjspcare-2018-aspabstracts.109.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Palliative treatment"

Xin, Wu, and Xue Tao. The efficacy and safety of neuromodulation in refractory epilepsy: a systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0042.

Повний текст джерела

Анотація:

Review question / Objective: To assess the efficacy and safety of different neuromodulation applied to the refractory epilepsy and provide a better choice for clinical practice. Condition being studied: Epilepsy is a frequent neurologic illness defined by bursts of hypersynchronized neural network activity that afflict about 1% of the global population. Unfortunately, roughly 30% of people with drug-resistant epilepsy (DRE) continue to experience seizures despite three anti-seizure drugs. In most cases, resective surgery, as the first-line treatment for DRE, is considered a curative therapy for achieving long-term seizure-free status, but about half of patients are not candidates for surgery due to a variety of factors such as multiple/diffuse/widespread seizure foci, epileptic foci arising from eloquent, primary generalized epilepsy, or patients unwilling to undergo surgery. Neuromodulation, albeit palliative, is an important alternative treatment for these individuals to prevent or decrease ictal episodes, which can affect the nervous system in a variety of ways.

Стилі APA, Harvard, Vancouver, ISO та ін.

Skelly, Andrea C., Eric Chang, Jessica Bordley, Erika D. Brodt, Shelley Selph, Rongwei Fu, Rebecca Holmes, et al. Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms. Agency for Healthcare Research and Quality (AHRQ), August 2023. http://dx.doi.org/10.23970/ahrqepccer265.

Повний текст джерела

Анотація:

Objectives. To evaluate the comparative effectiveness and harms of external beam radiation therapy (EBRT) for palliative treatment of metastatic bone disease (MBD). Data sources. Four electronic databases from 1985 to January 30, 2023; a targeted search for re-irradiation through January 30, 2023; reference lists; and a Federal Register notice. Review methods. Using predefined criteria and dual review, we selected randomized controlled trials (RCTs) and nonrandomized studies of interventions (NRSIs) comparing dose-fractionation schemes and EBRT delivery techniques (for initial radiation and re-irradiation, i.e., retreatment for recurrent or persistent pain) and EBRT alone versus in combination with other palliative treatments. Study risk of bias was assessed using predefined criteria. Strength of evidence (SOE) was assessed for the primary outcomes of pain, function, spinal cord compression relief, quality of life, and harms. Results. We included 53 RCTs and 31 NRSIs; most were fair quality. In patients receiving initial radiation for MBD there was a small increase in the likelihood of overall pain response (improved pain measures with stable or decreased analgesic use) for multiple fraction (MF) EBRT versus single fraction (SF) EBRT up to 4 weeks post-radiation therapy (SOE: moderate) and for higher dose (6 or 8 Gy) SF EBRT versus lower dose (4 Gy) SF EBRT up to 52 weeks post-radiation therapy (SOE: low). SF and MF EBRT did not differ at later followup (SOE: moderate) nor did comparisons of MF EBRT dose/fractions (SOE: moderate ≤12 weeks; low >12 weeks). Re-irradiation was more common with SF versus MF EBRT. Stereotactic body radiation therapy (SBRT) (SF or MF) was associated with a slightly higher (up to 20 weeks, SOE: low) and moderately higher (30 weeks; SOE: moderate) likelihood of overall pain response versus MF EBRT. For re-irradiation, SF and MF SBRT had a similar likelihood of overall pain response, as did SF versus MF EBRT (SOE: low for all). Harms may be similar across dose/fraction schemes and techniques; serious harms were rare. Comparative effectiveness evidence for EBRT was sparse. Conclusions. In patients with uncomplicated MBD receiving initial palliative radiotherapy, the likelihood of overall pain response for SF and MF EBRT is probably similar, particularly after 4 weeks; re-irradiation was more common with SF-EBRT. SF and MF SBRT may provide slightly greater likelihood of overall pain response versus MF EBRT; evidence is limited. SF and MF EBRT may have similar likelihoods of overall pain response in patients receiving re-irradiation. High-quality evidence comparing SBRT with EBRT is needed in populations with complicated and uncomplicated MBD, as is research on effectiveness of EBRT versus other treatments. Update: An addendum is located at the end of the main report, before the appendixes.

Стилі APA, Harvard, Vancouver, ISO та ін.

Ramsey, Imogen, Kate Kennedy, Deborah Forsythe, Micah Peters, Greg Sharplin, Nadia Corsini, and Marion Eckert. Cancer control plans. The Sax Institute, June 2020. http://dx.doi.org/10.57022/jkea9139.

Повний текст джерела

Анотація:

This review, commissioned by the NSW Cancer Institute, highlights key trends and common elements of cancer control plans from Australia and countries with health systems similar to NSW. It will be used as the basis for a discussion paper in the development of the next NSW Cancer Plan. A clear message from the review is the need for plans to be tailored to the local context, to consider the most prevalent cancers and at risk populations, to respond to the needs of stakeholders, to have detailed actionable outcomes, to be appropriately resourced and to have a clear plan for implementation and evaluation. Common elements of included plans were: prevention, screening and early detection, treatment, survivorship and palliative care, coordination between services, approaches to specific populations, research and training, workforce, implementation, evaluation and monitoring, and trends for cancer control

Стилі APA, Harvard, Vancouver, ISO та ін.

Chang, Ke-Vin. Ultrasonography for the Diagnosis of Carpal Tunnel Syndrome: A Protocol for an Umbrella Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0058.

Повний текст джерела

Анотація:

Review question / Objective: This meta-analysis aimed to compare the clinical effectiveness and safety between radioactive versus normal stent insertion for patients with malignant hilar obstruction. Condition being studied: Malignant hilar obstruction (MHO) is a common clinical condition that is caused by the hilar cholangiocarcinoma, gallbladder carcinoma, or hilar metastasis. Most of the patients with MHO underwent palliative biliary drainage or stening by an endoscopic or percutaneous approach until end of life. The previous studies suggested that that bilateral stent placement and the use of metal stents are superior to unilateral and plastic stents in the items of stent patency. However, bilateral stenting did not improve the patients’ overall survival (OS) because stent alone had no treatment effect on the tumors themselves. Although several treatment options, including chemotherapy, external radiation, intra-ductal brachytherapy, etc, has been used to prolong the stent patency and OS for patients with malignant biliary obstruction (MBO), intra-ductal brachytherapy using I-125 seeds has been widely used because of its persistent brachytherapeutic effect. To combine the I-125 seeds and metal stent together, many researchers have developed a radioactive stent (RS) for the patients with MBO. Many meta-analyses also confirmed that RS insertion was associated with significant longer stent patency and OS for patients with MBO when compared to normal stent (NS). However, whether RS can also provide a good effectiveness for patients with MHO is still unclear.

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!